BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jakab SS, Garcia-tsao G. Evaluation and Management of Esophageal and Gastric Varices in Patients with Cirrhosis. Clinics in Liver Disease 2020;24:335-50. [DOI: 10.1016/j.cld.2020.04.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu HM, Gong ZB. Efficacy of early re-ligation after endoscopic gastric glue injection combined with endoscopic variceal ligation in preventing rebleeding of esophagogastric varices in patients with cirrhosis. Shijie Huaren Xiaohua Zazhi 2022; 30(17): 748-755 [DOI: 10.11569/wcjd.v30.i17.748] [Reference Citation Analysis]
2 Douglas QZ. Variceal Bleeds in Patients with Cirrhosis. Critical Care Nursing Clinics of North America 2022. [DOI: 10.1016/j.cnc.2022.04.006] [Reference Citation Analysis]
3 Fugazza A, Khalaf K, Colombo M, Carrara S, Spadaccini M, Koleth G, Troncone E, Maselli R, Repici A, Anderloni A. Role of endoscopic ultrasound in vascular interventions: Where are we now? World J Gastrointest Endosc 2022; 14(6): 354-366 [DOI: 10.4253/wjge.v14.i6.354] [Reference Citation Analysis]
4 Mao G, Li C, Wang H, Jv YH, Zhang Y, Liu L, Tang M. Exploration on the Effect of Nonselective β-Receptor Blockers (NSBBs) on Hemodynamic Parameters in Complicated Liver Cirrhosis. BioMed Research International 2022;2022:1-8. [DOI: 10.1155/2022/7922906] [Reference Citation Analysis]
5 Al-Obaid LN, Bazarbashi AN, Ryou M. Variceal Bleeding: Beyond Banding. Dig Dis Sci 2022. [PMID: 35378681 DOI: 10.1007/s10620-022-07425-8] [Reference Citation Analysis]
6 Kim JH, Choe WH, Lee SY, Kwon SY, Sung IK, Park HS. Comparative study for predictability of type 1 gastric variceal rebleeding after endoscopic variceal ligation: High-frequency intraluminal ultrasound study. World J Clin Cases 2021; 9(34): 10566-10575 [PMID: 35004988 DOI: 10.12998/wjcc.v9.i34.10566] [Reference Citation Analysis]
7 Wang Y, Tu Y, Liu Z, Li H, Chen H, Cheng B, Fang X. Effects of Preoperative Oral Carbohydrate on Cirrhotic Patients under Endoscopic Therapy with Anesthesia: A Randomized Controlled Trial. Biomed Res Int 2021;2021:1405271. [PMID: 34540991 DOI: 10.1155/2021/1405271] [Reference Citation Analysis]
8 Grassi G, Lenci I, Signorello A, Milana M, Baiocchi L. Gastrointestinal endoscopy in cirrhotic patient: Issues on the table. World J Gastrointest Endosc 2021; 13(7): 210-220 [PMID: 34326942 DOI: 10.4253/wjge.v13.i7.210] [Reference Citation Analysis]
9 Lin Y, Li L, Yu D, Liu Z, Zhang S, Wang Q, Li Y, Cheng B, Qiao J, Gao Y. A novel radiomics-platelet nomogram for the prediction of gastroesophageal varices needing treatment in cirrhotic patients. Hepatol Int 2021;15:995-1005. [PMID: 34115257 DOI: 10.1007/s12072-021-10208-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Chevallier O, Guillen K, Comby PO, Mouillot T, Falvo N, Bardou M, Midulla M, Aho-Glélé LS, Loffroy R. Safety, Efficacy, and Outcomes of N-Butyl Cyanoacrylate Glue Injection through the Endoscopic or Radiologic Route for Variceal Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis. J Clin Med 2021;10:2298. [PMID: 34070534 DOI: 10.3390/jcm10112298] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Yoon KT, Liu H, Lee SS. β-blockers in advanced cirrhosis: More friend than enemy. Clin Mol Hepatol 2021;27:425-36. [PMID: 33317244 DOI: 10.3350/cmh.2020.0234] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Zanetto A, Barbiero G, Battistel M, Sciarrone SS, Shalaby S, Pellone M, Battistella S, Gambato M, Germani G, Russo FP, Burra P, Senzolo M. Management of portal hypertension severe complications. Minerva Gastroenterol (Torino) 2021;67:26-37. [PMID: 33140623 DOI: 10.23736/S2724-5985.20.02784-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Kreisel W, Schaffner D, Lazaro A, Trebicka J, Merfort I, Schmitt-Graeff A, Deibert P. Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension. Int J Mol Sci 2020;21:E6223. [PMID: 32872119 DOI: 10.3390/ijms21176223] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]